PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
BIT:PHN - Euronext Milan - IT0005274094 - Common Stock - Currency: EUR
Overall PHN gets a fundamental rating of 8 out of 10. We evaluated PHN against 13 industry peers in the Personal Care Products industry. PHN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PHN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make PHN suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
PHN had positive earnings in the past year.
In the past year PHN had a positive cash flow from operations.
Each year in the past 5 years PHN has been profitable.
PHN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
PHN has a better Return On Assets (18.91%) than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 36.18%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 23.97%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHN had an Average Return On Invested Capital over the past 3 years of 17.21%. This is significantly above the industry average of 11.95%.
The last Return On Invested Capital (23.97%) for PHN is above the 3 year average (17.21%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROIC | 23.97% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
The Profit Margin of PHN (13.77%) is better than 76.92% of its industry peers.
PHN's Profit Margin has declined in the last couple of years.
The Operating Margin of PHN (22.67%) is better than 100.00% of its industry peers.
In the last couple of years the Operating Margin of PHN has remained more or less at the same level.
The Gross Margin of PHN (95.55%) is better than 100.00% of its industry peers.
PHN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHN is creating value.
The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
The number of shares outstanding for PHN has been reduced compared to 5 years ago.
The debt/assets ratio for PHN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.24 indicates that PHN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.24, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PHN has a debt to FCF ratio of 1.16. This is a very positive value and a sign of high solvency as it would only need 1.16 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.16, PHN belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
PHN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
PHN's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. PHN outperforms 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 8.24 |
ROIC/WACC3
WACC7.98%
2.3 Liquidity
PHN has a Current Ratio of 2.29. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
PHN has a better Current ratio (2.29) than 92.31% of its industry peers.
A Quick Ratio of 2.02 indicates that PHN has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.02, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.72% over the past year.
PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.63% yearly.
PHN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.16%.
Measured over the past years, PHN shows a quite strong growth in Revenue. The Revenue has been growing by 16.59% on average per year.
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
3.2 Future
The Earnings Per Share is expected to grow by 12.90% on average over the next years. This is quite good.
Based on estimates for the next years, PHN will show a quite strong growth in Revenue. The Revenue will grow by 11.78% on average per year.
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
PHN is valuated rather expensively with a Price/Earnings ratio of 19.63.
Based on the Price/Earnings ratio, PHN is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
PHN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
PHN is valuated rather expensively with a Price/Forward Earnings ratio of 18.74.
PHN's Price/Forward Earnings ratio is in line with the industry average.
PHN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.63 | ||
| Fwd PE | 18.74 |
4.2 Price Multiples
61.54% of the companies in the same industry are more expensive than PHN, based on the Enterprise Value to EBITDA ratio.
PHN's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.22 | ||
| EV/EBITDA | 10.5 |
4.3 Compensation for Growth
PHN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 12.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.19
PEG (5Y)1.34
EPS Next 2Y15.44%
EPS Next 3Y12.9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.17%, PHN has a reasonable but not impressive dividend return.
PHN's Dividend Yield is a higher than the industry average which is at 2.55.
Compared to an average S&P500 Dividend Yield of 2.37, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
PHN pays out 35.05% of its income as dividend. This is a sustainable payout ratio.
PHN's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP35.05%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
BIT:PHN (7/9/2025, 11:20:29 AM)
47.5
+0.15 (+0.32%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.44%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap459.80M
Analysts82.86
Price Target83.64 (76.08%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP35.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-1.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.63 | ||
| Fwd PE | 18.74 | ||
| P/S | 2.72 | ||
| P/FCF | 22.22 | ||
| P/OCF | 18.5 | ||
| P/B | 7.13 | ||
| P/tB | 11.25 | ||
| EV/EBITDA | 10.5 |
EPS(TTM)2.42
EY5.09%
EPS(NY)2.54
Fwd EY5.34%
FCF(TTM)2.14
FCFY4.5%
OCF(TTM)2.57
OCFY5.41%
SpS17.49
BVpS6.66
TBVpS4.22
PEG (NY)1.19
PEG (5Y)1.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROCE | 41.7% | ||
| ROIC | 23.97% | ||
| ROICexc | 35.83% | ||
| ROICexgc | 57.7% | ||
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% | ||
| FCFM | 12.22% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score8
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.46 | ||
| Cap/Depr | 106.2% | ||
| Cap/Sales | 2.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.76% | ||
| Profit Quality | 88.74% | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 8.24 |
F-Score8
WACC7.98%
ROIC/WACC3
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
EBIT growth 1Y19.75%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y235.79%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y134.99%
OCF growth 3Y0.14%
OCF growth 5Y11.34%